Page last updated: 2024-08-21

dihydroergotamine and thromboxane b2

dihydroergotamine has been researched along with thromboxane b2 in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Burkel, WE; Graham, LM; Lindblad, B; Stanley, JC; Wakefield, TW1
Bellou, A; Gerard, P; Gillois, P; Guéant, JL; Lambert, H; Longrois, D; Mallié, JP; Montémont, C; Sainte-Laudy, J; Vauthier, E1

Other Studies

2 other study(ies) available for dihydroergotamine and thromboxane b2

ArticleYear
Lack of effect of dihydroergotamine on endothelial and smooth muscle cell proliferation and endothelial cell prostanoid production.
    Experientia, 1988, Mar-15, Volume: 44, Issue:3

    Topics: 6-Ketoprostaglandin F1 alpha; Animals; Cell Division; Dihydroergotamine; Dogs; Endothelium, Vascular; Muscle, Smooth, Vascular; Prostaglandins; Thromboxane B2

1988
Constitutive nitric oxide synthase inhibition combined with histamine and serotonin receptor blockade improves the initial ovalbumin-induced arterial hypotension but decreases the survival time in brown norway rats anaphylactic shock.
    Shock (Augusta, Ga.), 2003, Volume: 19, Issue:1

    Topics: Anaphylaxis; Animals; Arteries; Cimetidine; Dihydroergotamine; Dinoprostone; Eicosanoids; Enzyme Inhibitors; Heart; Histamine; Hypotension; Leukotriene C4; Male; Myocardium; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Ovalbumin; Pressure; Rats; Rats, Inbred BN; Receptors, Serotonin; Serotonin; Thromboxane B2; Time Factors

2003